Monica Holmberg, PharmD, BCPS

The FDA approved Duexis (ibuprofen and famotidine) tablets for the relief of the symptoms of rheumatoid arthritis and osteoarthritis and to decrease the risk of developing upper gastrointestinal ulcer.

The recent approval pf Yervoy (ipilimumab) for intravenous infusion offers the first treatment approved for patients with late-stage skin cancer.

The FDA approved Krystexxa (pegloticase) Injection for the treatment of chronic gout in adult patients who are refractory to conventional therapy.

Eurand Pharmaceuticals' Zenpep (pancrelipase) Delayed-Release Capsules have been approved by the FDA for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis or other conditions.

The FDA recently approved Centocor Ortho Biotech's Stelara (ustekinumab)for the treatment of adult patients with moderate-to-severe plaque psoriasis who are candidates for phototherapy or systemic therapy.

Astepro Nasal Spray 0.15% is the first nasal antihistamine to be available with once-daily dosing.

The Omron 1500PRO Ultra Premium Blood Pressure Monitor offers patients an accurate way to monitor their blood pressure at home.